The emerging therapy of the medication represents a exciting development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment